191-200 items (total 704)
Published on January 16, 2024
Blood Metabolite Composition Differs in Individuals with Severe COVID-19—Identifying Predictive Markers for Severe Disease Risk in Early Infection—
Office of Communications and Public Relations
Published on January 16, 2024
Developing a Pioneering Physics Theory as the Foundation for Predictive Medical Sciences—The Basis for Hybrid AI Combining Physics and AI Analysis—
Office of Communications and Public Relations
Published on January 16, 2024
Developed Advanced Network Monitoring and Control Technology for the Post-5G Era—Established Silent Failure Detection Technology Capable of Detecting Minute Packet Loss of Less Than 1%—
Office of Communications and Public Relations
Published on January 15, 2024
Successful Wireless Autonomous Control of a Semi-Autonomous Robot Hand and Arm Capable of Appropriate Force Adjustment—A Japan-First Initiative Enabling Real-Time Analysis of Haptic Information via 5G and MEC to Enhance Robot Mobility—
Office of Communications and Public Relations
Published on January 11, 2024
Successful Development of an Oral Nanoparticle Formulation for Safe and Effective Allergy Treatment—Hopes for a Therapeutic Drug to Halt the "Allergic March" Starting in Infancy—
Office of Communications and Public Relations
Published on January 11, 2024
Successful Observation of Emergent Inductance at Room Temperature and Low Magnetic Fields in Magnetic Thin Films on Flexible Substrates by Applying a "Staircase-Like Magnetic Field" to Efficiently Generate Magnetic Domain Walls—Promising for Ultra-Sensitive Magnetic Sensors
Office of Communications and Public Relations
Published on December 27, 2023
Students Submit Final Proposals to the University President for the 2023 Keio Student Conference
Office of Communications and Public Relations
Published on December 26, 2023
Keio Selected as Part of the Program for Forming Japan's Peak Research Universities (J-PEAKS)
Office of Communications and Public Relations
Published on December 22, 2023
Discovery of a New Antiviral Drug Candidate Expected to Cure Hepatitis B—New Compound iCDM-34 Suppresses Viral Genome Synthesis
Office of Communications and Public Relations
Published on December 22, 2023
Four Researchers from Keio University Selected among the World's Most Influential Researchers (Highly Cited Researchers 2023)
Office of Communications and Public Relations